← All stocks

Bionano Genomics, Inc.

BNGO Net buying
CIK 0001411690 #5156 in the set updated 17 Sep 2026
Bought (120 mo)
$332.09K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$72.40K
$0.00 on a plan · $72.40K straight out of an exercise
Sold at will
$0.00
0 of 1 sales
Net
+$259.69K
+$332.09K against sales at will

By person

19 insiders · 22 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Domain Partners VIII, L.P. entity
10% owner
$91.88K (1)
+$91.88K
943,878
$1.14M
Linney Yvonne
Director
$72.40K (1) scheduled
−$72.40K
0
$0.00
TWOMEY CHRISTOPHER J
Director
$61.25K (1)
+$61.25K
74,500
$90.23K
+645.0%
Mamuszka Hannah
Director
$50.00K (1)
+$50.00K
65,789
$79.68K
BARKER DAVID L
Director
$41.19K (2)
+$41.19K
58,364
$70.69K
Holmlin R. Erik
PRESIDENT AND CEO
$39.66K (5)
+$39.66K
6,682
$8.09K
Stewart Christopher P.
Chief Financial Officer
$33.42K (1)
+$33.42K
281,373
$340.80K
+2,488%
Luderer Albert
Interim Chief Executive
$9.70K (2)
+$9.70K
12,000
$14.53K
+200.0%
OLDAKOWSKI MARK
Chief Operating Officer
$4.99K (1)
+$4.99K
868
$1.05K
Zhou Quan
Director
5,668,017
$6.87M
+105.3%
WANG JUNFENG
Director
5,668,017
$6.87M
+105.3%
LC Fund VI, L.P. entity
10% owner
5,668,017
$6.87M
+105.3%
Shams Soheil
Chief Informatics Officer
5,325,378
$6.45M
Cao Han PHD
Chief Scientific Officer
112,936
$136.79K
+7,893%
Kama Gulsen
Chief Financial Officer
16,000
$19.38K
DP VIII Associates, L.P. entity
10% owner
6,891
$8.35K
Chaubey Alka
CHIEF MEDICAL OFFICER
620
$750.94
Adamchak Mark
Principal Accounting Officer
253
$306.43
−7.7%
Dixon Jonathan V.
General Counsel
239
$289.48

No percentages here. This company's share count has moved by a factor of 33.9 over the window, from 3,007,000 to 101,993,225 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Luderer Albert
4 Sep 2026
Interim Chief Executive
Buy indirect
4,000
$1.21
$4.84K
Luderer Albert
21 Aug 2026
Interim Chief Executive
Buy indirect
4,000
$1.22
$4.86K
Mamuszka Hannah
13 Jun 2023
Director
Buy
65,789
$0.76
$50.00K
Holmlin R. Erik
16 May 2023
President and CEO
Buy
15,000
$0.64
$9.64K
Stewart Christopher P.
12 May 2023
Chief Financial Officer
Buy
50,000
$0.67
$33.42K
Linney Yvonne
15 Aug 2022
Director
Sold after exercise
20,000
$3.62
$72.40K
BARKER DAVID L
7 Jul 2022
Director
Exercised, kept
44,470
$0.51
$22.68K
BARKER DAVID L
16 May 2022
Director
Buy
10,000
$1.60
$16.00K
Stewart Christopher P.
13 May 2022
Chief Financial Officer
Exercised, kept
60,000
$0.56
$33.60K
Holmlin R. Erik
29 Nov 2021
President and CEO
Buy indirect
150
$3.98
$597.00
Holmlin R. Erik
29 Nov 2021
President and CEO
Buy indirect
2,675
$3.99
$10.67K
Holmlin R. Erik
29 Nov 2021
President and CEO
Buy indirect
2,200
$3.99
$8.77K
Stewart Christopher P.
19 Nov 2021
Chief Financial Officer
Exercised, kept
22,500
$0.56
$12.60K
Stewart Christopher P.
26 May 2021
Chief Financial Officer
Exercised, kept
25,000
$0.56
$14.00K
OLDAKOWSKI MARK
18 Jan 2019
Chief Operating Officer
Exercised, kept
6,000
$1.30
$7.80K
Domain Partners VIII, L.P.
23 Aug 2018
10% owner
Buy
15,000
$6.13
$91.88K
Domain Partners VIII, L.P.
23 Aug 2018
10% owner
Exercised, kept
337,694
$4.59
$1.55M
DP VIII Associates, L.P.
23 Aug 2018
10% owner
Exercised, kept
2,505
$4.59
$11.50K
TWOMEY CHRISTOPHER J
23 Aug 2018
Director
Buy
10,000
$6.13
$61.25K
OLDAKOWSKI MARK
23 Aug 2018
Chief Operating Officer
Buy
815
$6.13
$4.99K
Holmlin R. Erik
23 Aug 2018
President and CEO
Buy
1,630
$6.13
$9.98K
BARKER DAVID L
21 Aug 2018
Director
Buy
3,894
$6.47
$25.19K

What was left out

Form 4 filings counted 185
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 17,141,832
History held since 27 Aug 2018